Longevity eye cream
US-2024423898-A1 · Dec 26, 2024 · US
US9901534B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9901534-B2 |
| Application number | US-201213821855-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 21, 2012 |
| Priority date | Feb 22, 2011 |
| Publication date | Feb 27, 2018 |
| Grant date | Feb 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to compositions comprising banyan tree, lotus, and clover serum fractions. A method of improving the appearance of a hyperpigmented spot may comprise the step of applying a composition comprising an effective amount of banyan tree serum fraction, lotus serum fraction, and clover serum fraction to a hyperpigmented spot on a skin surface, wherein the composition is applied for a period of time sufficient to improve the appearance of the hyperpigmented spot. The method may include the step of identifying a hyperpigmented spot on a facial skin surface. Other methods as disclosed include a method for improving the appearance of post-inflammatory hyperpigmentation.
Opening claim text (preview).
What is claimed is: 1. A serum fraction blend suitable for use in formulating topically applied skin compositions, said blend comprising: a. Banyan tree serum fraction; b. Lotus serum fraction; and c. Clover serum fraction, wherein said serum fraction blend is effective in inhibiting melanin synthesis, wherein the percentage of melanin synthesis inhibition for said serum fraction blend is greater than the percentage of melanin synthesis inhibition for each of the individual serum fraction blend components when added together. 2. The serum fraction blend of claim 1 , wherein each of said banyan tree, lotus, and clover serum fractions are produced by the process comprising: a. separating plant cell juice from clean, fresh, un-wilted plant matter to obtain fresh plant cell juice, wherein no exogenous liquid is added prior or during said separating; b. filtering said fresh plant cell juice to obtain fiber-free cell juice; and c. fractionating said fiber-free cell juice to obtain said serum fractions. 3. The serum fraction blend of claim 1 which comprises: a. from 0.001% to 15% Banyan tree serum fraction; b. from 0.001% to 15% Lotus serum fraction; and c. from 0.001% to 15% Clover serum fraction. 4. The serum fraction blend of claim 1 which comprises: a. from 0.002% to 10% Banyan tree serum fraction; b. from 0.002% to 10% Lotus serum fraction; and c. from 0.002% to 10% Clover serum fraction. 5. The serum fraction blend of claim 1 which comprises: a. from 0.025% to 10% Banyan tree serum fraction; b. from 0.025% to 10% Lotus serum fraction; and c. from 0.025% to 10% Clover serum fraction. 6. The serum fraction blend of claim 1 which comprises: a. from 0.05% to 5% Banyan tree serum fraction; b. from 0.05% to 5% Lotus serum fraction; and c. from 0.05% to 5% Clover serum fraction.
Emollients or protectives, e.g. against radiation · CPC title
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae · CPC title
for chemically bleaching or whitening the skin · CPC title
Anti-ageing preparations · CPC title
Magnoliopsida [dicotyledons] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.